Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle

Human Gene Therapy

Volumn 21, Issue 10, 2010, Pages 1343-1348

  Qiao, Chunping ^a   Zhang, Wei ^b   Yuan, Zhenhua ^a   Shin, Jin Hong ^b   Li, Jianbin ^a   Jayandharan, Giridhara R ^c   Zhong, Li ^d   Srivastava, Arun ^c   Xiao, Xiao ^a   Duan, Dongsheng ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; LUCIFERASE; PHENYLALANINE; TYROSINE;

ADENOVIRUS; ADENOVIRUS 6; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DRUG MEGADOSE; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SKELETAL MUSCLE; VIRUS CAPSID;

ALKALINE PHOSPHATASE; ANIMALS; CAPSID PROTEINS; DEPENDOVIRUS; DNA COPY NUMBER VARIATIONS; GENE DOSAGE; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; LUCIFERASES, FIREFLY; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MUTATION; PHENYLALANINE; TRANSDUCTION, GENETIC; TRANSGENES; TYROSINE;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MIRIDAE; MUS;

EID: 77958102381     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.003     Document Type: Article

References (25)

1. Bish, L.T., Morine, K., Sleeper, M.M., Sanmiguel, J., Wu, D., Gao, G., Wilson, J.M., and Sweeney, H.L. (2008). Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum. Gene Ther. 19, 1359-1368.
2. Blankinship, M.J., Gregorevic, P., Allen, J.M., Harper, S.Q., Harper, H., Halbert, C.L., Miller, D.A., and Chamberlain, J.S. (2004). Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol. Ther. 10, 671-678.
3. Daya, S., and Berns, K.I. (2008). Gene therapy using adeno-associated virus vectors. Clin. Microbiol. Rev. 21, 583-593.
4. Ferrari, F.K., Samulski, T., Shenk, T., and Samulski, R.J. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
5. Gao, G., Vandenberghe, L.H., and Wilson, J.M. (2005). New recombinant serotypes of AAV vectors. Curr. Gene Ther. 5, 285-297.
6. Gao, G.P., Alvira, M.R., Wang, L., Calcedo, R., Johnston, J., and Wilson, J.M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859.
7. Ghosh, A., Yue, Y., Long, C., Bostick, B., and Duan, D. (2007). Efficient whole-body transduction with trans-splicing adeno-associated viral vectors. Mol. Ther. 15, 750-755.
8. Harper, S.Q., Hauser, M.A., Dellorusso, C., Duan, D., Crawford, R.W., Phelps, S.F., Harper, H.A., Robinson, A.S., Engelhardt, J.F., Brooks, S.V., and Chamberlain, J.S. (2002). Modular flexibility of dystrophin: Implications for gene therapy of Du-chenne muscular dystrophy. Nat. Med. 8, 253-261.
9. High, K.A. (2004). Clinical gene transfer studies for hemophilia B. Semin. Thromb. Hemost. 30, 257-267.
10. Kaplitt, M.G., Feigin, A., Tang, C., Fitzsimons, H.L., Mattis, P., Lawlor, P.A., Bland, R.J., Young, D., Strybing, K., Eidelberg, D., and During, M.J. (2007). Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: An open label, phase I trial. Lancet 369, 2097-2105.
11. Li, J., Wang, D., Qian, S., Chen, Z., Zhu, T., and Xiao, X. (2003). Efficient and long-term intracardiac gene transfer in 5-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors. Gene Ther. 10, 1807-1813
12. Maguire, A.M., Simonelli, F., Pierce, E.A., Pugh, E.N., Jr., Min-gozzi, F., Bennicelli, J., Banfi, S., Marshall, K.A., Testa, F., Surace, E.M., Rossi, S., Lyubarsky, A., Arruda, V.R., Konkle, B., Stone, E., Sun, J., Jacobs, J., Dell'osso, L., Hertle, R., Ma, J.X., Redmond, T.M., Zhu, X., Hauck, B., Zelenaia, O., Shindler, K.S., Maguire, M.G., Wright, J.F., Volpe, N.J., McDonnell, J.W., Auricchio, A., High, K.A., and Bennett, J. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358, 2240-2248.
13. Maguire, A.M., High, K.A., Auricchio, A., Wright, J.F., Pierce, E.A., Testa, F., Mingozzi, F., Bennicelli, J.L., Ying, G.S., Rossi, S., Fulton, A., Marshall, K.A., Banfi, S., Chung, D.C., Morgan, J.I., Hauck, B., Zelenaia, O., Zhu, X., Raffini, L., Coppieters, F., De Baere, E., Shindler, K.S., Volpe, N.J., Surace, E.M., Acerra, C., Lyubarsky, A., Redmond, T.M., Stone, E., Sun, J., McDonnell, J.W., Leroy, B.P., Simonelli, F., and Bennett, J. (2009). Age-dependent effects of RPE65 gene therapy for Le-ber's congenital amaurosis: A phase 1 dose-escalation trial. Lancet 374, 1597-1605.
14. Manno, C.S., Chew, A.J., Hutchison, S., Larson, P.J., Herzog, R.W., Arruda, V.R., Tai, S.J., Ragni, M.V., Thompson, A., Ozelo, M., Couto, L.B., Leonard, D.G., Johnson, F.A., McClelland, A., Scallan, C., Skarsgard, E., Flake, A.W., Kay, M.A., High, K.A., and Glader, B. (2003). AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101, 2963-2972.
15. Muzyczka, N., and Warrington, K.H., Jr. (2005). Custom ade-no-associated virus capsids: The next generation of re-combinant vectors with novel tropism. Hum. Gene Ther. 16, 408-416.
16. Samulski, R.J., Berns, K.I., Tan, M., and Muzyczka, N. (1982). Cloning of adeno-associated virus into pBR322: Rescue of in-tact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. U.S.A. 79, 2077-2081.
17. Wang, B., Li, J., and Xiao, X. (2000). Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl. Acad. Sci. U.S.A. 97, 13714-13719.
18. Wang, B., Li, J., Fu, F.H., Chen, C., Zhu, X., Zhou, L., Jiang, X., and Xiao, X. (2008). Construction and analysis of compact muscle-specific promoters for AAV vectors. Gene Ther. 15, 1489-1499.
19. Wu, Z., Asokan, A., and Samulski, R.J. (2006). Adeno-associated virus serotypes: Vector toolkit for human gene therapy. Mol. Ther. 14, 316-327.
20. Xiao, X., Li, J., and Samulski, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098-8108. (Pubitemid 26339120)
21. Yang, L., Jiang, J., Drouin, L.M., Agbandje-McKenna, M., Chen, C., Qiao, C., Pu, D., Hu, X., Wang, D.Z., Li, J., and Xiao, X. (2009). A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection. Proc. Natl. Acad. Sci. U.S.A. 106, 3946-3951.
22. Yu, C.Y., Yuan, Z., Cao, Z., Wang, B., Qiao, C., Li, J., and Xiao, X. (2009). A muscle-targeting peptide displayed on AAV2 im-proves muscle tropism on systemic delivery. Gene Ther. 16, 953-962.
23. Yue, Y., Ghosh, A., Long, C., Bostick, B., Smith, B.F., Kornegay, J.N., and Duan, D. (2008). A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skele-tal muscle transduction in dogs. Mol. Ther. 16, 1944-1952.
24. Zhong, L., Zhao, W., Wu, J., Li, B., Zolotukhin, S., Govindasamy, L., Agbandje-McKenna, M., and Srivastava, A. (2007). A dual role of EGFR protein tyrosine kinase signaling in ubiquitina-tion of AAV2 capsids and viral second-strand DNA synthesis. Mol. Ther. 15, 1323-1330.
25. Zhong, L., Li, B., Mah, C.S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R.W., Zolotukhin, I., Warrington, K.H., Jr., Weigel-Van Aken, K.A., Hobbs, J.A., Zolotukhin, S., Muzyczka, N., and Srivastava, A. (2008). Next generation of adeno-associated virus 2 vectors: Point muta-tions in tyrosines lead to high-efficiency transduction at lower doses. Proc. Natl. Acad. Sci. U.S.A. 105, 7827-7832